About: Arovella Therapeutics Limited, a biotechnology company, engages in the development of therapies for the treatment of cancer in Australia and internationally. It product pipeline includes ALA-101 CD19, which is a next-generation off-the-shelf CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukaemias; ALA-105 CLDN18.2 for targeting Claudin 18.2, which is expressed in gastric cancer, gastroesophageal junction cancer, pancreatic cancer, and lung and ovarian cancer; and IL-12-TM for treating solid tumors. The company was formerly known as Suda Pharmaceuticals Ltd and changed its name to Arovella Therapeutics Limited in October 2021. Arovella Therapeutics Limited was incorporated in 1999 and is based in Preston, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.05 (+3.92%)
ALA ASX Arovella Therapeutics Ltd
Arovella Therapeutics Ltd share price
Atividade de preço de ALA
Último preço
$ 0,050
Variação (24h)
0,00 AUD (3,92%)
Volume
811.10K
Volume (média 4 sem.)
-
Abertura
$ 0,05
Variação do dia
$ 0,05 - $ 0,06
Fechamento anterior
$ 0,05
Último negócio
30 Oct, 3:05 am GMT+0
Atrasado
30 Oct, 3:05 am GMT+0
ALA price performance
Atrasado
30 Oct, 3:05 am GMT+0
quote.marketSignals